Real-time Analytics News for Week Ending May 8
In this week's real-time analytics news: A focus on DevOps, observability, low code, partnerships, data management, and Kubernetes.
In this week's real-time analytics news: A focus on DevOps, observability, low code, partnerships, data management, and Kubernetes.
Sponsored by In partnership with Center for Edge Computing and 5G The edge exists wherever data is acted on to create immediate, essential value. It’s where trailblazers in every industry are leveraging edge computing and 5G to transform business models, operations, and user experiences. Recent Activity Industry Use Cases Additional Resources What is Edge Computing? […]
As was the case last year, rather than seeing an endless string of traditional webinar talks, the virtual ODSC East conference put the attendee into an online version of a normal conference environment.
In this week's real-time analytics news: Several AI educational efforts launch, NVIDIA intros new tools for data scientists, and several offerings that address streaming analytics.
In this week's real-time analytics news: Many announcements from NVIDIA GTC (GPU Technology Conference) where companies introduced new products or services that use NVIDIA compute platforms.
In this week's real-time analytics news: Deloitte offers an AI-as-a-service solution, Oracle and Katana Graph boost performance with Xeon Ice Lake processors, and more.
With its reliance on a community of physically dispersed individuals and flexibility of adoption, open-source data science is becoming an even more attractive choice among cash-strapped governments, non-profits, and businesses.
Bogging down ML engineers with poor quality data that requires extensive manual processes impacts product quality and new feature speed to market.
Researchers are exploring how perceptive AI might be used to evaluate traffic pattern scenarios and make city driving safer.
AI could transform clinical trials for the better, unlocking the next generation of drug discovery and building new pipelines for pharmaceutical companies.